| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PLX4720 | CCLE | pan-cancer | AAC | -0.082 | 0.06 |
| mRNA | Irinotecan | CCLE | pan-cancer | AAC | -0.1 | 0.06 |
| mRNA | L-685458 | CCLE | pan-cancer | AAC | -0.063 | 0.2 |
| mRNA | TKI258 | CCLE | pan-cancer | AAC | -0.062 | 0.2 |
| mRNA | PD-0332991 | CCLE | pan-cancer | AAC | -0.064 | 0.2 |
| mRNA | PHA-665752 | CCLE | pan-cancer | AAC | 0.057 | 0.2 |
| mRNA | lapatinib | CCLE | pan-cancer | AAC | 0.045 | 0.3 |
| mRNA | Nutlin-3 | CCLE | pan-cancer | AAC | -0.04 | 0.4 |
| mRNA | Nilotinib | CCLE | pan-cancer | AAC | 0.04 | 0.4 |
| mRNA | Panobinostat | CCLE | pan-cancer | AAC | -0.028 | 0.5 |